Back

Mortality and device intervention in patients with a history of atrial fibrillation: a substudy of APPRAISE ATP

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of arrhythmias and gender differences Device Treatment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Giuseppe Boriani

Modena Polyclinic Modena University Hospital, Modena (Italy)

7 More presentations in this session

Presentation thumbnail
Mexiletine in drug-refractory ventricular arrhythmias: real-world effectiveness and tolerability
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides
Presentation thumbnail
Accelerated biological aging increases the 10-year mortality risk in patients with coronary artery disease after percutaneous coronary intervention
Doctor M. Liu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Sex differences in long-term arrhythmogenic and mortality outcomes in patients with hypertrophic cardiomyopathy: a 20-year longitudinal observational study
Doctor D. Silva (Rochester, US)
Abstract Slides
Presentation thumbnail
Immune-epicardial adiposity, associated with coronary artery disease, is modulated by semaglutide
Doctor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract Slides
Presentation thumbnail
From systemic adiposity to local epicardial adipose tissue targets: uncovering novel mechanisms and biomarkers in atrial fibrillation
Mr S. Huang (Beijing, CN)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms of arrhythmias and gender differences

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of atrial fibrillation with outcomes in left ventricular assist device carriers- insights from the PCHF-VAD registry
29 June 2021
thumbnail
Congress Presentation
Inappropriate shocks in ICD/CRT-D patients: are they as harmful as we think?
21 March 2026
thumbnail
Congress Presentation
Generalizability of the EAST-AFNET 4 trial: assessing outcomes of early rhythm-control therapy in patients with atrial fibrillation
27 August 2021
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources